サリチル酸マグネシウムの世界市場の評価：純度別、用途別、地域別、機会、予測（2017年～2031年）

世界のサリチル酸マグネシウムの市場規模は、2023年の3,050万米ドルから2031年に4,404万米ドルに達し、予測期間の2024年～2031年にCAGRで4.7％の成長が見込まれます。この市場成長は、研究開発活動の活発化、化粧品産業の拡大、鎮痛剤としてのサリチル酸マグネシウム消費の増加によるものと考えられます。

市場成長を支えるその他の主な促進要因として、炎症治療や疼痛管理に用いる非ステロイド性抗炎症薬（NSAIDs）に対する需要の増加、世界各地における関節炎の有病率の上昇、老年人口の増加などがあります。例えば、BioMed Central Ltdによると、2021年に参入企業の77％がNSAIDsを頻繁に購入し、サリチル酸マグネシウムの需要を促進しています。ドラッグデリバリーシステムや製剤の強化に向けたさまざまなメーカーの取り組みの高まりと、一般消費者のサリチル酸マグネシウムのさまざまな利点に関する意識の高まりが、世界のサリチル酸マグネシウム市場の需要を押し上げています。サリチル酸マグネシウムに関連するさまざまな利点としては、その他の非ステロイド性抗炎症薬とは対照的に胃腸の副作用リスクが低いこと、鎮痛・抗炎症作用があることなどがあります。

化粧品産業の急速な拡大も市場拡大を支える大きな要因です。この拡大は、主要化粧品企業による製品のプロモーションやマーケティング活動への投資の増加に起因しています。消費者の間で製品の認知度が高まり、世界中のさまざまな地域で化粧品へのアクセスが向上していることも、化粧品への要求を強化する主な要因です。

例えば、Indian Brand Equity Foundation（IBEF）の推計によると、インドの化粧品産業はCAGR 25％で成長し、2025年までに200億米ドルに達すると予測されています。一方、世界の化粧品産業は2025年までに4,500億米ドルに達し、CAGRで4.3％の成長が予測されています。このように、サリチル酸マグネシウムはさまざまな化粧品製剤の保存料として使用されているため、化粧品産業の拡大動向は市場に有利な成長機会を提供します。

関節炎の流行が世界のサリチル酸マグネシウムの市場規模を拡大

関節炎のような慢性疾患では、サリチル酸マグネシウムを含む薬は医師の指示に従って服用されます。その効果が認められるまで薬を定期的に服用すると、2週間ほどかかることもあります。さまざまな非ステロイド性抗炎症薬は、シクロオキシゲナーゼ酵素の非選択的阻害剤として働き、シクロオキシゲナーゼ-2とシクロオキシゲナーゼ-1のアイソザイムを阻害します。シクロオキシゲナーゼはアラキドン酸からのトロンボキサンとプロスタグランジンの生成を触媒し、炎症におけるメッセンジャー分子として作用します。したがって、世界中のさまざまな地域における関節炎の流行が、市場に有利な成長機会をもたらしています。

関節炎の有病率は、身体的不活性、精神的または身体的健康の悪化、BMIと年齢の増加によって上昇しています。Office of Disease Prevention and Health Promotion（OASH）の推計によると、関節炎患者数は2040年までに米国の成人のうち7,840万人に増加すると予測されています。サリチル酸マグネシウムは関節のこわばり、腫れ、痛みを軽減するため、この増加がサリチル酸マグネシウムの需要を促進し、予測期間の市場成長を促進しています。

化粧品への利用の増加が市場成長を後押し

サリチル酸マグネシウムは化粧品の保存料として使用されることが多く、微生物による腐敗などから保護し、消費者の健康に大きく寄与します。サリチル酸マグネシウムは、その他の保存料の中でも、特に水を含む化粧品製剤に不可欠なものです。

化粧品の利用が急速に増加していることも、世界のサリチル酸マグネシウム市場の成長を支える大きな要因です。化粧品に対する要求の高まりは、可処分所得の増加、美容動向や化粧品使用の利点に対する意識の高まりによるものと考えられます。例えば、米国では毎年約492億米ドル相当の化粧品が販売されており、平均して米国人は毎月244～313米ドルを化粧品に費やしています。このように一般消費者の化粧品への投資が増加しているため、サリチル酸マグネシウムは化粧品にさまざまな用途が見出されていることから、市場は予測期間に大きな成長が見込まれます。そのため、化粧品への要求が高まり、市場の成長が促進されます。

当レポートでは、世界のサリチル酸マグネシウム市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のサリチル酸マグネシウム市場の見通し（2017年～2031年）

• 市場規模と予測
  • 金額
  • 数量
• 純度別
  • 98%未満
  • 99%超
• 用途別
  • 化学試薬
  • 製薬
  • 化粧品添加物
  • その他
• 地域別
  • 北米
  • 南米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
• 市場シェア：企業別（2023年）

第5章 世界のサリチル酸マグネシウム市場の見通し：地域別（2017年～2031年）

• 北米
  • 市場規模と予測
  • 純度別
  • 用途別
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド
• アジア太平洋
  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン
• 南米
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第6章 市場マッピング（2023年）

• 純度別
• 用途別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸入輸出分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進要因
• 成長抑制要因（課題、抑制要因）

第9章 規制枠組みとイノベーション

• 特許情勢
• 規制当局の承認
• イノベーション/新技術

第10章 主要企業の情勢

• マーケットリーダー上位5社の競合マトリクス
• マーケットリーダー上位5社の市場収益分析（2023年）
• 合併と買収/合弁事業（該当する場合）
• SWOT分析（市場企業5社）
• 特許分析（該当する場合）

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• Pharm-Rx
• Biosynth Carbosynth
• Kreative Organics Private Limited
• JQC (Huayin) Pharmaceutical
• Dr. Raju's Pharma Solutions
• Shanghai Yayu Biological
• Ralington Pharma
• Satyam Pharma Chem Private Limited
• New Asia Pharmaceutical
• Chongqing Yaxianglong Biomedical

第14章 戦略的推奨

第15章 お問い合わせ、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1.Global Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 2.Global Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 3.Global Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 4.Global Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 5.Global Magnesium Salicylate Market Share (%), By Region, 2017-2031F
• Figure 6.North America Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 7.North America Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 8.North America Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 9.North America Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 10.North America Magnesium Salicylate Market Share (%), By Country, 2017-2031F
• Figure 11.United States Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 12.United States Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 13.United States Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 14.United States Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 15.Canada Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 16.Canada Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 17.Canada Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 18.Canada Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 19.Mexico Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 20.Mexico Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 21.Mexico Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 22.Mexico Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 23.Europe Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 24.Europe Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 25.Europe Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 26.Europe Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 27.Europe Magnesium Salicylate Market Share (%), By Country, 2017-2031F
• Figure 28.Germany Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 29.Germany Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 30.Germany Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 31.Germany Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 32.France Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 33.France Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 34.France Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 35.France Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 36.Italy Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 37.Italy Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 38.Italy Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 39.Italy Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 40.United Kingdom Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 41.United Kingdom Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 42.United Kingdom Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 43.United Kingdom Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 44.Russia Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 45.Russia Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 46.Russia Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 47.Russia Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 48.Netherlands Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 49.Netherlands Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 50.Netherlands Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 51.Netherlands Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 52.Spain Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 53.Spain Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 54.Spain Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 55.Spain Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 56.Turkey Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 57.Turkey Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 58.Turkey Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 59.Turkey Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 60.Poland Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 61.Poland Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 62.Poland Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 63.Poland Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 64.South America Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 65.South America Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 66.South America Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 67.South America Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 68.South America Magnesium Salicylate Market Share (%), By Country, 2017-2031F
• Figure 69.Brazil Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 70.Brazil Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 71.Brazil Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 72.Brazil Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 73.Argentina Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 74.Argentina Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 75.Argentina Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 76.Argentina Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 77.Asia-Pacific Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 78.Asia-Pacific Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 79.Asia-Pacific Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 80.Asia-Pacific Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 81.Asia-Pacific Magnesium Salicylate Market Share (%), By Country, 2017-2031F
• Figure 82.India Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 83.India Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 84.India Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 85.India Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 86.China Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 87.China Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 88.China Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 89.China Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 90.Japan Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 91.Japan Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 92.Japan Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 93.Japan Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 94.Australia Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 95.Australia Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 96.Australia Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 97.Australia Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 98.Vietnam Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 99.Vietnam Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 100.Vietnam Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 101.Vietnam Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 102.South Korea Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 103.South Korea Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 104.South Korea Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 105.South Korea Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 106.Indonesia Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 107.Indonesia Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 108.Indonesia Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 109.Indonesia Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 110.Philippines Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 111.Philippines Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 112.Philippines Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 113.Philippines Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 114.Middle East & Africa Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 115.Middle East & Africa Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 116.Middle East & Africa Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 117.Middle East & Africa Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 118.Middle East & Africa Magnesium Salicylate Market Share (%), By Country, 2017-2031F
• Figure 119.Saudi Arabia Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 120.Saudi Arabia Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 121.Saudi Arabia Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 122.Saudi Arabia Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 123.UAE Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 124.UAE Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 125.UAE Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 126.UAE Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 127.South Africa Magnesium Salicylate Market, By Value, In USD Million, 2017-2031F
• Figure 128.South Africa Magnesium Salicylate Market, By Volume, in Kilotons, 2017-2031F
• Figure 129.South Africa Magnesium Salicylate Market Share (%), By Purity, 2017-2031F
• Figure 130.South Africa Magnesium Salicylate Market Share (%), By Application, 2017-2031F
• Figure 131.By Purity Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 132.By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 133.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Global magnesium salicylate market is projected to witness a CAGR of 4.7% during the forecast period 2024-2031, growing from USD 30.5 million in 2023 to USD 44.04 million in 2031F. The market growth can be attributed to the increasing research and development activities, expansion of the cosmetics industry, and rising consumption of magnesium salicylate as an analgesic.

Other major drivers supporting the global magnesium salicylate market growth include increased requirement for nonsteroidal anti-inflammatory drugs (NSAIDs) for treating inflammation and management of pain, rising prevalence of arthritis in various regions across the globe, and growing geriatric population. For instance, according to BioMed Central Ltd, in 2021, 77% of the participants frequently purchased NSAIDs, thus, propelling the requirement for magnesium salicylate. The rising efforts by various manufacturers towards enhancing their drug delivery systems and formulations, coupled with augmenting awareness about the various benefits of magnesium salicylate among the general population, are bolstering the global magnesium salicylate market demand. Different advantages associated with magnesium salicylate include a lowered risk of gastrointestinal side effects as opposed to other NSAIDs and the provision of pain-relieving and anti-inflammatory effects.

The rapid expansion of the cosmetics industry is another major factor supporting the market expansion. The expansion can be attributed to the increasing investments by the leading cosmetic companies in product promotion and marketing activities. The augmenting product awareness among consumers and increasing accessibility to cosmetics in various regions across the globe is another major factor bolstering their requirements.

For instance, according to the estimates of the Indian Brand Equity Foundation (IBEF), the Indian cosmetics industry is expected to grow at a CAGR of 25%, reaching a value of USD 20 billion by 2025. Meanwhile, the global cosmetics industry is anticipated to reach USD 450 billion by 2025, growing at a CAGR of 4.3%. Thus, the trend of cosmetics industry expansion will offer lucrative growth opportunities to the market as magnesium salicylate is used as a preservation in various cosmetic formulations.

Growing Prevalence of Arthritis Boosts Global Magnesium Salicylate Market Size

In ongoing health conditions, such as arthritis, the medication containing magnesium salicylate is taken as per the physician's directions. It may take up to two weeks of regularly taking the medication until its benefits are observed. Various non-steroidal anti-inflammatory drugs work as non-selective inhibitors of the cyclooxygenase enzyme, inhibiting cyclooxygenase-2 and cyclooxygenase-1 isoenzymes. Cyclooxygenase catalyzes the formation of thromboxane and prostaglandins from arachidonic acid, which acts as a messenger molecule in inflammation. Hence, the increasing prevalence of arthritis in various regions across the globe is providing lucrative growth opportunities to the market.

The prevalence of arthritis is rising due to physical inactivity, worsening mental or physical health, and increasing body mass index and age. According to the estimates of the Office of Disease Prevention and Health Promotion (OASH), the number of cases of arthritis is projected to rise to 78.4 million in adults in the United States by 2040. The increase is propelling the requirement for magnesium salicylate, as it reduces joint stiffness, swelling, and pain, thus bolstering the growth of the market over the forecast period.

Increasing Utilization of Cosmetics Supports the Market Growth

Magnesium salicylate is often used as a preservative in cosmetic products, providing protection against microbial spoilage, among other things, and hence significantly contributing to consumer health. Magnesium salicylate, among other preservatives, is particularly essential in cosmetic formulations that contain water, as various microorganisms can reproduce and colonize in aqueous environments with ease.

The rapid increase in utilization of cosmetics is another major driver supporting the global magnesium salicylate market growth. The rising requirement for cosmetics can be attributed to increasing disposable incomes and growing awareness beauty trends and benefits of using cosmetic products. For instance, approximately USD 49.2 billion worth of cosmetic products are sold in the United States every year and on an average, Americans spend somewhere between USD 244 and USD 313 on cosmetics each month. Due to such increasing investments in cosmetic products by the general population, the market for magnesium salicylate is expected to witness significant growth over the forecast period as the product finds various applications in cosmetics. Thus, bolstering their requirement and augmenting the growth of the market.

North America Accounts for Significant Global Magnesium Salicylate Market Share

The increasing emphasis of various regional market players towards developing advanced magnesium salicylate formulations with fewer side effects and enhanced efficacy is one of the major factors supporting the growth of the North America magnesium salicylate market. The increasing accessibility to various non-steroidal anti-inflammatory drugs including magnesium salicylate due to their growing availability across online distribution channels is favorably influencing the market expansion in North America.

For instance, according to a survey commissioned by the ASOP Global Foundation in May 2021, approximately 42% of the American population shop online for medications due to the various benefits offered by the services with regards to cost and convenience. Due to it, the establishment of online pharmacies is rising in the region, resulting in an increased accessibility of various medications including non-steroidal anti-inflammatory drugs such as magnesium salicylate, aiding the expansion of the market. The growth of the market in North America is supported by the continuous efforts of the market players based in the region to expand their product portfolio.

More than 99% Pure Magnesium Salicylate Boosts Global Magnesium Salicylate Market Demand

The growing requirement for magnesium salicylate with more than 99% purity can be attributed to the rapid expansion of the cosmetics industry in various regions across the globe. For instance, according to the estimates of Cosmetics Europe, the Europe cosmetics and personal care products market was valued at USD 95 billion (EUR 88 billion) in 2022. The various markets for cosmetics and personal care products in Europe are France with USD 13.96 billion (EUR 12.9 billion), the United Kingdom with 11.37 billion (EUR 10.5 billion), Germany with USD 15.48 billion (EUR 14.3 billion), and Italy with USD 12.45 billion (EUR 11.5 billion), and others. Due to this rapid growth of the cosmetics industry, the demand for magnesium salicylate is increasing as the product finds various applications in different cosmetic formulations as a preservative. Thus, propelling the requirement for more than 99% pure magnesium salicylate and augmenting the growth of the market.

Increased Pharmaceutical Applications Bolster Global Magnesium Salicylate Market Expansion

Magnesium salicylate finds applications in the pharmaceutical sector as a pain relief for treating moderate to mild pain. The oral dosage for adults is 1090 mg, three times a day or 650 mg every four hours. The dose can be increased to approximately 3600-4800 mg/day in three to four doses as per the requirements of the patient. Individuals that have pseudo allergic reactions to acetylsalicylic acid/ nonsteroidal anti-inflammatory drugs are usually able to tolerate drugs that are weak cyclooxygenase-1 inhibitors, such as magnesium salicylate. The product is used in the formation of medication that reduces various substances in the body responsible for causing inflammation, pain, and fever. Magnesium salicylate in combination with diphenhydramine is used for treating back pain without causing drowsiness.

Various life science companies are actively investing in opening new manufacturing facilities to broaden their customer base and increase their profits. For instance, Aragen, one of the leading providers of research and development solutions is making an investment of USD 30 million in their new biologics manufacturing facility that will be based in India. The facility is expected to become operational by the third quarter of 2024, with the first manufacturing suite to become operational by the third quarter of 2025. Approximately 160,000 square ft. facility will have various GMP manufacturing suites and a process development laboratory with single-use bioreactors. Hence, due to increasing development of such facilities, the pharmaceutical sector is expected to witness significant growth in the coming years, propelling the requirement for magnesium salicylate as a pharmaceutical and chemical reagent and boosting the market's growth.

Future Market Scenario (2024 - 2031F)

According to the global magnesium salicylate market analysis, increasing efforts of various manufacturers to develop enhanced formulations of magnesium salicylate that offer limited side effects and improved efficacy will positively influence the market expansion over the forecast period. The growth of geriatric population is expected to bolster the requirement for pain relief medication containing magnesium salicylate, augmenting the market demand. The increase in requirement for pain relief medication can be attributed to the enhanced susceptibility of older population to chronic pain causing disorders.

Key Players Landscape and Outlook

The market expansion is supported by the increasing efforts of various manufacturers to enhance their manufacturing capabilities. For instance, in 2022, Biosynth Carbosynth, one of the leading custom synthesis and life science reagents manufacturing companies, along with Jinan Shengquan Group Share-Holding Co, Ltd. acquired Kexing Biopharmaceutical Co, Ltd's raw material factory. The acquisition is expected to allow larger production volumes, more flexibility, and enhanced production reliability. With this strategic acquisition, Biosynth Carbosynth aims to expand its manufacturing operations, delivering a wide range of products and increasing its sales. The acquisition, along with the company's unrivaled expertise in complex organic chemistry, is expected to boost the production of various chemicals, including magnesium salicylate, propelling the expansion of the market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Magnesium Salicylate Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1.By Value
  • 4.1.2.By Volume
• 4.2.By Purity
  • 4.2.1.Less than 98%
  • 4.2.2.98% to 99%
  • 4.2.3.More than 99%
• 4.3.By Application
  • 4.3.1.Chemical Reagent
  • 4.3.2.Pharmaceutical
  • 4.3.3.Cosmetic Additives
  • 4.3.4.Others
• 4.4.By Region
  • 4.4.1.North America
  • 4.4.2.South America
  • 4.4.3.Europe
  • 4.4.4.Asia-Pacific
  • 4.4.5.Middle East & Africa
• 4.5.By Company Market Share (%), 2023

5.Global Magnesium Salicylate Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
    • 5.1.1.2.By Volume
  • 5.1.2.By Purity
    • 5.1.2.1.Less than 98%
    • 5.1.2.2.98% to 99%
    • 5.1.2.3.More than 99%
  • 5.1.3.By Application
    • 5.1.3.1.Chemical Reagent
    • 5.1.3.2.Pharmaceutical
    • 5.1.3.3.Cosmetic Additives
    • 5.1.3.4.Others
  • 5.1.4.United States*
    • 5.1.4.1.Market Size & Forecast
    • 5.1.4.1.1.By Value
    • 5.1.4.1.2.By Volume
    • 5.1.4.2.By Purity
    • 5.1.4.2.1.Less than 98%
    • 5.1.4.2.2.98% to 99%
    • 5.1.4.2.3.More than 99%
    • 5.1.4.3.By Application
    • 5.1.4.3.1.Chemical Reagent
    • 5.1.4.3.2.Pharmaceutical
    • 5.1.4.3.3.Cosmetic Additives
    • 5.1.4.3.4.Others
  • 5.1.5.Canada
  • 5.1.6.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East & Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Purity
• 6.2.By Application
• 6.3.By Region

7.Macro Environment and Industry Structure

• 7.1.Supply Demand Analysis
• 7.2.Import Export Analysis
• 7.3.Value Chain Analysis
• 7.4.PESTEL Analysis
  • 7.4.1.Political Factors
  • 7.4.2.Economic System
  • 7.4.3.Social Implications
  • 7.4.4.Technological Advancements
  • 7.4.5.Environmental Impacts
  • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5.Porter's Five Forces Analysis
  • 7.5.1.Supplier Power
  • 7.5.2.Buyer Power
  • 7.5.3.Substitution Threat
  • 7.5.4.Threat from New Entrant
  • 7.5.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

• 9.1.Patent Landscape
• 9.2.Regulatory Approvals
• 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)
• 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

• 13.1.Pharm-Rx
  • 13.1.1.Company Details
  • 13.1.2.Key Management Personnel
  • 13.1.3.Products & Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Key Market Focus & Geographical Presence
  • 13.1.6.Recent Developments
• 13.2.Biosynth Carbosynth
• 13.3.Kreative Organics Private Limited
• 13.4.JQC (Huayin) Pharmaceutical
• 13.5.Dr. Raju's Pharma Solutions
• 13.6.Shanghai Yayu Biological
• 13.7.Ralington Pharma
• 13.8.Satyam Pharma Chem Private Limited
• 13.9.New Asia Pharmaceutical
• 13.10.Chongqing Yaxianglong Biomedical

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer